[go: up one dir, main page]

DE69006728D1 - Abbildungsverfahren für arteriosklerotische plaque. - Google Patents

Abbildungsverfahren für arteriosklerotische plaque.

Info

Publication number
DE69006728D1
DE69006728D1 DE90906551T DE69006728T DE69006728D1 DE 69006728 D1 DE69006728 D1 DE 69006728D1 DE 90906551 T DE90906551 T DE 90906551T DE 69006728 T DE69006728 T DE 69006728T DE 69006728 D1 DE69006728 D1 DE 69006728D1
Authority
DE
Germany
Prior art keywords
imaging method
arteriosclerotic plaque
arteriosclerotic
plaque
imaging
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE90906551T
Other languages
English (en)
Other versions
DE69006728T2 (de
Inventor
Peter Daddona
Harvey Berger
Rodger Mcever
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Biotech Inc
Original Assignee
Centocor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centocor Inc filed Critical Centocor Inc
Application granted granted Critical
Publication of DE69006728D1 publication Critical patent/DE69006728D1/de
Publication of DE69006728T2 publication Critical patent/DE69006728T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1018—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/809—Drug, bio-affecting and body treating compositions involving immunoglobulin or antibody fragment, e.g. fab', fv, fc, heavy chain or light chain
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/866—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving immunoglobulin or antibody fragment, e.g. fab', fab, fv, fc, heavy chain or light chain

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69006728T 1989-04-06 1990-04-05 Abbildungsverfahren für arteriosklerotische plaque. Expired - Fee Related DE69006728T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/334,459 US5026537A (en) 1989-04-06 1989-04-06 Methods for imaging atherosclerotic plaque
PCT/US1990/001864 WO1990011676A2 (en) 1989-04-06 1990-04-05 Method for imaging atherosclerotic plaque

Publications (2)

Publication Number Publication Date
DE69006728D1 true DE69006728D1 (de) 1994-03-24
DE69006728T2 DE69006728T2 (de) 1994-08-25

Family

ID=23307309

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69006728T Expired - Fee Related DE69006728T2 (de) 1989-04-06 1990-04-05 Abbildungsverfahren für arteriosklerotische plaque.

Country Status (6)

Country Link
US (1) US5026537A (de)
EP (1) EP0469035B1 (de)
JP (1) JP3078315B2 (de)
CA (1) CA2051096A1 (de)
DE (1) DE69006728T2 (de)
WO (1) WO1990011676A2 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6025477A (en) * 1986-03-31 2000-02-15 Calenoff; Emanuel Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof
US5811248A (en) * 1986-03-31 1998-09-22 Charter Ventures Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof
US5955584A (en) * 1986-03-31 1999-09-21 Charter Ventures Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof
US7087722B1 (en) 1988-12-29 2006-08-08 Savient Pharmaceuticals, Inc. Fibrin binding domain polypeptides and uses and methods of producing same
US5270030A (en) * 1988-12-29 1993-12-14 Bio-Technology General Corp. Fibrin binding domain polypeptide and method of producing
CA2010321C (en) * 1989-02-21 2004-04-06 Thomas F. Tedder Lymphocyte-associated cell surface protein
US5364612A (en) * 1991-05-06 1994-11-15 Immunomedics, Inc. Detection of cardiovascular lesions
US5334369A (en) * 1991-06-11 1994-08-02 Medical University Of South Carolina Platelet receptor antagonists useful in detecting intravascular platelet aggregation
US5811447A (en) 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
JPH05304982A (ja) * 1991-11-08 1993-11-19 Takara Shuzo Co Ltd キメラ型抗体
US5770609A (en) * 1993-01-28 1998-06-23 Neorx Corporation Prevention and treatment of cardiovascular pathologies
US6306421B1 (en) 1992-09-25 2001-10-23 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6395494B1 (en) 1993-05-13 2002-05-28 Neorx Corporation Method to determine TGF-β
CA2145093C (en) * 1992-09-25 2007-04-10 Lawrence Leroy Kunz Therapeutic inhibitor of vascular smooth muscle cells
US6251920B1 (en) 1993-05-13 2001-06-26 Neorx Corporation Prevention and treatment of cardiovascular pathologies
ATE174344T1 (de) * 1993-01-25 1998-12-15 Dana Farber Cancer Inst Inc Chimäre selektine erhältlich durch domänenaustauch und ihre verwendungen
US5595722A (en) * 1993-01-28 1997-01-21 Neorx Corporation Method for identifying an agent which increases TGF-beta levels
US6491938B2 (en) 1993-05-13 2002-12-10 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6663881B2 (en) 1993-01-28 2003-12-16 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5981568A (en) 1993-01-28 1999-11-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6197789B1 (en) 1995-06-07 2001-03-06 Neorx Corporation Prevention and treatment of cardiovascular pathologies with tamoxifen analogues
JPH08510451A (ja) * 1993-05-13 1996-11-05 ネオルックス コーポレイション 異常増殖性平滑筋細胞に関連した病因の予防及び治療
US5699801A (en) * 1995-06-01 1997-12-23 The Johns Hopkins University Method of internal magnetic resonance imaging and spectroscopic analysis and associated apparatus
US7611533B2 (en) 1995-06-07 2009-11-03 Cook Incorporated Coated implantable medical device
EP0856893B1 (de) 1996-12-31 2002-05-02 STMicroelectronics, Inc. Struktur und Bauelement zur Auswahl von Entwurfsmöglichkeiten in einem integrierten Schaltkreis
US6727102B1 (en) 1997-06-20 2004-04-27 Leuven Research & Development Vzw Assays, antibodies, and standards for detection of oxidized and MDA-modified low density lipoproteins
US6309888B1 (en) * 1998-09-04 2001-10-30 Leuven Research & Development Vzw Detection and determination of the stages of coronary artery disease
JP2003534291A (ja) * 2000-05-19 2003-11-18 ザ センター フォー ブラッド リサーチ インク Ｐ−セレクチン活性の変調による止血障害の診断及び治療方法
US6613083B2 (en) 2001-05-02 2003-09-02 Eckhard Alt Stent device and method
US20050181451A1 (en) * 2004-02-12 2005-08-18 Bates Harold M. Detection of asymptomatic coronary artery disease using atherogenic proteins and acute phase reactants
US20070014721A1 (en) * 2005-06-30 2007-01-18 Harris Thomas D Hydrazide conjugates as imaging agents
US20090317329A2 (en) * 2005-07-05 2009-12-24 Baker Idi Heart & Diabetes Institute Holdings Limited Anticoagulation agent and uses thereof
DE102017002521B4 (de) 2017-03-16 2020-08-27 Carl Freudenberg Kg Dichtungsanordnung, Dichtring und Laufring einer solchen und Verfahren zur Herstellung einer solchen Dichtungsanordnung

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3875299A (en) * 1972-05-05 1975-04-01 Medi Physics Inc Technetium labeled tin colloid radiopharmaceuticals
US4036945A (en) * 1976-05-03 1977-07-19 The Massachusetts General Hospital Composition and method for determining the size and location of myocardial infarcts
US4359453A (en) * 1978-04-07 1982-11-16 Gordon Robert T Atherosclerosis treatment method
US4577636A (en) * 1982-11-23 1986-03-25 The Beth Israel Hospital Association Method for diagnosis of atherosclerosis
US4610241A (en) * 1984-07-03 1986-09-09 Gordon Robert T Atherosclerosis treatment method
US4820505A (en) * 1985-04-04 1989-04-11 Scripps Clinic And Research Foundation Detection of activated platelets with antibodies to thrombospondin
US4877599A (en) * 1986-11-10 1989-10-31 New England Deaconess Hospital Corporation Detection of vascular disease with labelled antibodies

Also Published As

Publication number Publication date
US5026537A (en) 1991-06-25
JP3078315B2 (ja) 2000-08-21
DE69006728T2 (de) 1994-08-25
EP0469035B1 (de) 1994-02-16
WO1990011676A2 (en) 1990-10-18
JPH04504421A (ja) 1992-08-06
CA2051096A1 (en) 1990-10-07
EP0469035A1 (de) 1992-02-05

Similar Documents

Publication Publication Date Title
DE69006728D1 (de) Abbildungsverfahren für arteriosklerotische plaque.
DE69022343D1 (de) Überprüfungssystem.
DE3887277D1 (de) Werkträger für eine rolltreppe.
FI905832A0 (fi) Anordning.
NO913063D0 (no) Ett-trinnstest for absolutte tellinger.
FI951596L (fi) Menetelmä 10-desasetyylibakkatiini-III:n saamiseksi
NO903190L (no) Fremgangsmaate for klorering av sukrose-b-estere.
NO900543L (no) Fremgangsmaate for retningsbestemmelse i borehull.
DE69023450D1 (de) Generator für Topologie-unhabhängige Referenzsignale.
KR910000587A (ko) 하이드로포밀화 방법
DE3764783D1 (de) Laserapparat.
DE3889831D1 (de) Laser-Apparat.
DE3871706D1 (de) Konturenmessmethode.
DE69017580D1 (de) Bilderzeugungsverfahren.
DE69032077D1 (de) Fotoresist für nahes U.V.
DE3879547D1 (de) Laser-apparat.
DE68924687D1 (de) Bildherstellungsverfahren.
DE69004713D1 (de) Bilderzeugungsverfahren.
DE3854236D1 (de) Laser-Apparat.
FI920800A0 (fi) En method och en anordning foer olineaera medelvaerdeskompenserade maetningar.
DE69010520D1 (de) Bilderzeugungsapparat.
DE69015155D1 (de) Strahlteiler für farbabbildungsvorrichtung.
ES2022617B3 (es) Metodo para obtener epiclorohidrinas.
BG93509A (bg) Метод за получаване на 2-хидрокси-3-фенокси- пропиламиносъединения
FI922025A0 (fi) Metod foer framstaellning av cellulosa- massa.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee